Jazz Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.

CEO

Bruce C. Cozadd

CEOBruce C. Cozadd

Employees

2,800

Employees2,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2005

Founded2005

Employees

2,800

Employees2,800

JAZZ Key Statistics

Market cap

6.75B

Market cap6.75B

Price-Earnings ratio

17.75

Price-Earnings ratio17.75

Dividend yield

—

Dividend yield—

Average volume

542.05K

Average volume542.05K

High today

$110.50

High today$110.50

Low today

$107.60

Low today$107.60

Open price

$108.66

Open price$108.66

Volume

399.91K

Volume399.91K

52 Week high

$146.70

52 Week high$146.70

52 Week low

$106.61

52 Week low$106.61

JAZZ News

Yahoo Finance 2d

Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community - Yahoo Finance

Originally published by Jazz Pharmaceuticals NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Purple Day spotlights epilepsy and the challenges that people face...

Seeking Alpha 7d

Jazz Pharmaceuticals: Cheap But Complicated - Seeking Alpha

Jon Feingersh Photography Inc Today, we are going to take a more in-depth look at Jazz Pharmaceuticals plc (NASDAQ:JAZZ). The company has vigorously defended i...

Analyst ratings

80%

of 20 ratings

Buy

80%

Hold

20%

Sell